![]() |
![]() |
|
|
Table of Contents
Cardiometabolic Risk Management ContributorsCME InformationDisclosuresIntroductionScott M. Grundy, MD, PhD
Cardiometabolic Risk Assessment: An Approach to the Prevention of Cardiovascular Disease and Diabetes MellitusAbu R. Vasudevan, MBBS, MD, MRCP (UK) The Endocannabinoid System: A New Approach to Control Cardiovascular DiseaseChristopher P. Cannon, MD
The Metabolic Basis of Atherogenic DyslipidemiaAaron I. Vinik, MD, PhD, FCP, MACP
A Constellation of Complications: The Metabolic SyndromeScott M. Grundy, MD, PhD
Managing Cardiovascular Risk in Patients with Metabolic SyndromeRichard W. Nesto, MD
Pharmacotherapy to Reduce Visceral FatGeorge L. Blackburn, MD, PhD The Metabolic Syndrome, Hyperlipidemia, and Insulin ResistanceVivian A. Fonseca, MD
Literature ReviewsCME Test Qustions, Answer Sheet, and Evaluation FormTo receive FREE CME credit: This program was supported by an educational grant from Sanofi-Synthelabo Inc., a member of The sanofi-aventis Group |
Guest Editor Scott M. Grundy, MD, PhD
Release Date of Activity: |
|
![]() |
||
Copyright © Excerpta Medica, Inc. | Privacy Policy |
||